An Expanded Access Program for Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
Clinical trial NCT04256265 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04256265
- Sponsor
- Genentech, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.